UK markets close in 5 hours 45 minutes
  • FTSE 100

    5,751.48
    -25.02 (-0.43%)
     
  • FTSE 250

    17,767.48
    -20.34 (-0.11%)
     
  • AIM

    969.08
    -3.52 (-0.36%)
     
  • GBP/EUR

    1.1065
    -0.0012 (-0.11%)
     
  • GBP/USD

    1.3093
    -0.0050 (-0.38%)
     
  • BTC-GBP

    9,844.38
    +1,422.79 (+16.89%)
     
  • CMC Crypto 200

    258.39
    +13.50 (+5.51%)
     
  • S&P 500

    3,435.56
    -7.56 (-0.22%)
     
  • DOW

    28,210.82
    -97.97 (-0.35%)
     
  • CRUDE OIL

    40.18
    +0.15 (+0.37%)
     
  • GOLD FUTURES

    1,919.50
    -10.00 (-0.52%)
     
  • NIKKEI 225

    23,474.27
    -165.19 (-0.70%)
     
  • HANG SENG

    24,786.13
    +31.71 (+0.13%)
     
  • DAX

    12,462.18
    -95.46 (-0.76%)
     
  • CAC 40

    4,818.85
    -35.10 (-0.72%)
     

Global POC Clinical Chemistry and Immunodiagnostic Industry to 2024 - Emerging Technologies and Their Applications

Research and Markets
·3-min read

Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "2024 POC Clinical Chemistry and Immunodiagnostic Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers" report has been added to ResearchAndMarkets.com's offering.

This new report provides a comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. The report is available by section, and can be customized to specific information needs and budget.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation
Review of the POC clinical chemistry and immunodiagnostic market segments, including their dynamics, trends, structure, size, growth and major suppliers.

Five-year test volume and reagent sales forecasts clinical chemistry procedures by market segment:

  • Physician Offices/Group Practices

  • Emergency Rooms

  • Operating/Recovery Suites

  • ICUs/CCUs

  • Cancer Clinics

  • Ambulatory Care Centers

  • Surgery Centers

  • Nursing Homes

  • Birth Centers

Sales and Market Share Analysis

  • Sales and market shares of major reagent and instrument suppliers.

Routine Clinical Chemistry Tests

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Blood Gases, BUN (Blood Urea Nitrogen), Calcium, Cholesterol, Cholinesterase, Creatinine, CK-MB, Electrolytes (Carbon Dioxide/Bicarbonate, Chloride, Potassium, Sodium), Ferritin, Follate/Folic Acid, Fructosamine, GGT, Glucose, HDL, Iron, LDH, Magnesium, Phosphorus, Potassium, Protein, Sodium, Triglycerides, Troponin, Uric Acid, Urinalysis, Vitamin B12.

Endocrine Function Tests

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, TSH.

Therapeutic Drug Monitoring (TDM) Tests

Amikacin, Carbamazepine, Digoxin, Gentamicin, Lidocaine, Lithium, Methotrexate, Phenobarbital, Phenytoin/Dilatin, NAPA/Procainamide, Quinidine, Theophylline, Tobramycin, Valproic Acid, Vancomycin.

Immunoprotein Tests

C3, C4, CRP, IgA, IgE Specific, IgE Total, IgG, Immunoglobulins, Protein Electrophoresis, and others.

Drugs of Abuse

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine, Propoxyphene, and others.

Technology Review

  • Emerging technologies and their applications for POC testing.

  • Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Strategic Recommendations

  • Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.

  • Design criteria for POC testing products.

  • Alternative business expansion strategies.

  • Potential market entry barriers and risks.

Competitive Assessments

  • Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

The companies analyzed in the report include:

  • Abbott Laboratories

  • Agilent Technologies

  • Beckman Coulter/Danaher

  • bioMerieux

  • Bio-Rad

  • DiaSorin

  • Eiken Chemical

  • Fujirebio

  • Grifols

  • Instrumentation Laboratory/Werfen

  • Kyowa Medex

  • Ortho-Clinical Diagnostics

  • PerkinElmer

  • Quest Diagnostics

  • Roche

  • Siemens Healthineers

  • Sysmex

  • Thermo Fisher

  • Tosoh

  • Wako

For more information about this report visit https://www.researchandmarkets.com/r/hmn738

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900